LINC01122 was low expressed in Fig. 5E and hsa-miR-372-3p, hsa-miR-34c-5p and hsa-miR-449a were overexpressed, while hsa-miR-23c and hsa-miR-490-3p were low expressed in PRAD in (Fig. 5F). This evidence concerns the gene LINC01122 and prostate adenocarcinoma.